Scientists test new brain drug in healthy seniors
NCT ID NCT01747213
Summary
This early study tested the safety of a new drug called BNC, which is being developed for Alzheimer's disease. Researchers gave single doses to 75 healthy volunteers aged 55 and older to see how their bodies processed the drug and to check for side effects. The study was designed to find a safe dose range before testing in people with Alzheimer's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Harbor Hospital Center
Baltimore, Maryland, United States
-
National Institute on Aging, Clinical Research Unit
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.